# hCG Supplementation in Frozen-Thawed Embryo Transfer Cycle

> **NCT00398229** · PHASE2 · COMPLETED · sponsor: **Hadassah Medical Organization** · enrollment: 300 (estimated)

## Conditions studied

- Fertility Agents, Female

## Interventions

- **DRUG:** s.c. human chorionic gonadotropin (Ovitrelle)

## Key facts

- **NCT ID:** NCT00398229
- **Lead sponsor:** Hadassah Medical Organization
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-11
- **Primary completion:** —
- **Final completion:** 2008-05
- **Target enrollment:** 300 (ESTIMATED)
- **Last updated:** 2009-01-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00398229

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00398229, "hCG Supplementation in Frozen-Thawed Embryo Transfer Cycle". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT00398229. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*